19-8851267-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_001414686.1(MUC16):c.44073+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0034 in 1,602,198 control chromosomes in the GnomAD database, including 161 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.018 ( 88 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 73 hom. )
Consequence
MUC16
NM_001414686.1 intron
NM_001414686.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.212
Genes affected
MUC16 (HGNC:15582): (mucin 16, cell surface associated) This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 19-8851267-C-G is Benign according to our data. Variant chr19-8851267-C-G is described in ClinVar as [Benign]. Clinvar id is 3044590.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.063 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC16 | NM_001414686.1 | c.44073+9G>C | intron_variant | NP_001401615.1 | ||||
MUC16 | NM_001401501.2 | c.43647+9G>C | intron_variant | NP_001388430.1 | ||||
MUC16 | NM_001414687.1 | c.43527+9G>C | intron_variant | NP_001401616.1 | ||||
MUC16 | NM_024690.2 | c.43425+9G>C | intron_variant | NP_078966.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC16 | ENST00000710609.1 | c.43545+9G>C | intron_variant | ENSP00000518375.1 | ||||||
MUC16 | ENST00000397910.8 | c.43425+9G>C | intron_variant | 5 | ENSP00000381008.2 | |||||
MUC16 | ENST00000710610.1 | c.34251+9G>C | intron_variant | ENSP00000518376.1 |
Frequencies
GnomAD3 genomes AF: 0.0184 AC: 2798AN: 152134Hom.: 87 Cov.: 33
GnomAD3 genomes
AF:
AC:
2798
AN:
152134
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00450 AC: 1067AN: 237294Hom.: 25 AF XY: 0.00343 AC XY: 442AN XY: 128854
GnomAD3 exomes
AF:
AC:
1067
AN:
237294
Hom.:
AF XY:
AC XY:
442
AN XY:
128854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00182 AC: 2641AN: 1449946Hom.: 73 Cov.: 29 AF XY: 0.00160 AC XY: 1152AN XY: 721124
GnomAD4 exome
AF:
AC:
2641
AN:
1449946
Hom.:
Cov.:
29
AF XY:
AC XY:
1152
AN XY:
721124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0185 AC: 2811AN: 152252Hom.: 88 Cov.: 33 AF XY: 0.0178 AC XY: 1325AN XY: 74426
GnomAD4 genome
AF:
AC:
2811
AN:
152252
Hom.:
Cov.:
33
AF XY:
AC XY:
1325
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MUC16-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at